Introduction
Colostrum, rich in nutrients and antibodies, is essential for providing passive immunity to newborn calves. The concentration of Immunoglobulin G (IgG) in colostrum is a key factor in determining its quality, and Brix refractometry is commonly used on farms as an indirect measure of IgG concentration in colostrum. Feeding calves with high-quality colostrum during the first hours of life is crucial for ensuring adequate IgG transfer, as calves strictly rely on it to develop disease resistance (Figure 1). However, the quality of maternal colostrum can vary significantly among cows within the same herd. In this context, enriching maternal colostrum with a colostrum replacer has emerged as an effective strategy to improve quality by increasing levels of IgG, nutrients, and bioactive compounds.
Figure 1. Graphical representation of the transfer of passive immunity mechanism in newborn calves.
Brix % and variability of maternal colostrum
Figure 2. Adapted from Quigley et al. (2013). Distribution of total protein in maternal colostrum estimated through Brix refractometry
Figure 3. Modified from Lopez et al. (2023).
These results demonstrate that improving the quality of maternal colostrum through enrichment with a colostrum replacer is possible, as evidenced by the lack of differences in serum IgG levels, health status, and productivity in the calves across both treatments. At SCCL, there are a series of recommendations for enriching colostrum on the farm. It is considered that any colostrum with a Brix percentage of 22% or lower should be enriched to achieve an adequate IgG mass. Table 1 shows the classification of colostrum based on its Brix percentage and the corresponding recommendation.Table 1. Recommendations for enriching maternal colostrum with a colostrum replacer.
Table 2. Colostrum powder calculations to enrich fresh colostrum.
Figure 4. Key points of an adequate colostrum management protocol.
Conclusion
Lucía Pisoni, Juliana Mergh Leão, José María Rodríguez, Isela Ceballos, and Marina Godoy
Department of Clinical Research, The Saskatoon Colostrum Company Ltd., Saskatoon, Canada